Market verdict: Bull run to continue in new Samvat
Despite the record run in the past year and challenges concerning the earnings growth, Indian equities look poised for another year of double-digit gains in Samvat 2074. Read more
Device lobby AdvaMed wants US to stop import benefits to Indian firms
Multinational medical device lobby AdvaMed has asked the United States Trade Representative (USTR) to do away with import duty benefits given to Indian companies. The National Pharmaceutical Pricing Authority (NPPA) slashed the price of coronary stent by 80 per cent and orthopaedic knee implants by 50